Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Tandem Autologous/Allogeneic Stem Cell Transplantation for Multiple myeloma: Long-Term Outcome of a Retrospective Study

Claire Fabre, Jalil Bennani, Alain Brebion, Jean Mendiboure, Vincent Ribrag, Christophe Ferme, Nathalie Auger, Naziha Menasria, Annelise Bennaceur-Griscelli, Frédéric Troalen, Valérie Lapierre, Jean-Henri Bourhis

Blood (2008) 112 (11): 4389.

https://doi.org/10.1182/blood.V112.11.4389.4389

Published: 2008

Journal Articles

Laparoscopic Splenectomy for Hematologic Disorders: A Safe Procedure.

Christophe Ghys, MD, Elie Capelluto, MD, A. Baize, MS, Nathalie Meuleman, MD, Jalil Bennani, MD, Marc Libertalis, MD, Guy Bernard Cadiere, MD,PhD, Dominique Bron, MD,PhD

Blood (2006) 108 (11): 5523.

https://doi.org/10.1182/blood.V108.11.5523.5523

Published: 2006

Journal Articles

Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stem Cells (MSC) Infusion for Treatment of Metachromatic Leukodystrophy (MLD): A Case Report.

Nathalie Meuleman, MD, C. Rocha, MD, Jalil Bennani, MD, Tatiana Tondreau, PhD, Alain Delforge, MD, Philippe Lewalle, MD, Philippe Martiat, PhD, Laurence Lagneaux, PhD, Dominique Bron, PhD

Blood (2006) 108 (11): 5255.

https://doi.org/10.1182/blood.V108.11.5255.5255

Published: 2006

Journal Articles

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BSc, Virginie Misplon, BSc, Jalil Bennani, MD, PhD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2005) 106 (11): 2912.

https://doi.org/10.1182/blood.V106.11.2912.2912

Published: 2005

Journal Articles

Doubling Time of Soluble CD23 Is an Additional Prognostic Factor in ZAP 70 Positive CLL Patients.

Nathalie Meuleman, MD, Laurence Lagneaux, PhD, Jalil Bennani, MD, Alain Delforge, Dominique Bron, PhD

Blood (2005) 106 (11): 5020.

https://doi.org/10.1182/blood.V106.11.5020.5020

Published: 2005

Journal Articles

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Dominique Bron, MD PhD, Van Hyunh, MD, Virginie Dewilde, MD, Jalil Bennani, MD, Philippe Lewalle, MD, Phuong Huynh, MD, Rita Leroy, Patrick Crombez, Louisette Debusscher, MD, Walter Feremans, MD, PhD, Michel Bernier, MD, Philippe Martiat, MD

Blood (2004) 104 (11): 5044.

https://doi.org/10.1182/blood.V104.11.5044.5044

Published: 2004

Journal Articles

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BS, Virginie Misplon, Laurence Lagneaux, PhD, Koen Theunissen, MD, PhD, Jalil Bennani, MD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2004) 104 (11): 4975.

https://doi.org/10.1182/blood.V104.11.4975.4975

Published: 2004

NARROW

Tandem Autologous/Allogeneic Stem Cell Transplantation for Multiple myeloma: Long-Term Outcome of a Retrospective Study

Laparoscopic Splenectomy for Hematologic Disorders: A Safe Procedure.

Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stem Cells (MSC) Infusion for Treatment of Metachromatic Leukodystrophy (MLD): A Case Report.

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Doubling Time of Soluble CD23 Is an Additional Prognostic Factor in ZAP 70 Positive CLL Patients.

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Email alerts

ASH Publications

American Society of Hematology

Tandem Autologous/Allogeneic Stem Cell Transplantation for Multiple myeloma: Long-Term Outcome of a Retrospective Study

Laparoscopic Splenectomy for Hematologic Disorders: A Safe Procedure.

Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stem Cells (MSC) Infusion for Treatment of Metachromatic Leukodystrophy (MLD): A Case Report.

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Doubling Time of Soluble CD23 Is an Additional Prognostic Factor in ZAP 70 Positive CLL Patients.

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only